News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
18,260 Results
Type
Article (1860)
Company Profile (4)
Press Release (16395)
Multimedia
Podcasts (9)
Webinars (5)
Section
Business (4311)
Career Advice (430)
Deals (901)
Drug Delivery (15)
Drug Development (1876)
Employer Resources (19)
FDA (465)
Job Trends (402)
News (8377)
Policy (1630)
Tag
2027 Genetown Standard (1)
2027 Pharm Country Standard (1)
Academia (85)
Accelerated approval (1)
Adcomms (2)
Allergies (9)
Alliances (796)
ALS (4)
Alzheimer's disease (45)
Antibody-drug conjugate (ADC) (3)
Approvals (441)
Artificial intelligence (15)
Autoimmune disease (2)
Automation (1)
Bankruptcy (37)
Best Places to Work (339)
BIOSECURE Act (1)
Biosimilars (4)
Biotechnology (3)
Bladder cancer (1)
Brain cancer (5)
Breast cancer (17)
Cancer (118)
Cardiovascular disease (4)
Career advice (341)
Career pathing (7)
CAR-T (1)
CDC (19)
Cell therapy (20)
Clinical research (1547)
Collaboration (40)
Complete response letters (6)
COVID-19 (87)
CRISPR (2)
C-suite (19)
Cystic fibrosis (2)
Data (173)
Denatured (3)
Depression (8)
Diabetes (25)
Diagnostics (121)
Diversity (1)
Diversity, equity & inclusion (8)
Drug discovery (7)
Drug pricing (30)
Drug shortages (2)
Duchenne muscular dystrophy (10)
Earnings (2230)
Editorial (12)
Employer branding (2)
Employer resources (18)
Events (3197)
Executive appointments (8)
FDA (562)
Fibrodysplasia Ossificans Progressiva (1)
Funding (22)
Gene editing (8)
Generative AI (1)
Gene therapy (66)
GLP-1 (28)
Government (321)
Grass and pollen (1)
Guidances (14)
Healthcare (630)
HIV (1)
Huntington's disease (1)
IgA nephropathy (2)
Immunology and inflammation (7)
Indications (4)
Infectious disease (95)
Inflammatory bowel disease (5)
Inflation Reduction Act (4)
Intellectual property (6)
Interviews (130)
IPO (523)
IRA (6)
Job creations (66)
Job search strategy (268)
JPM (3)
Labor market (5)
Layoffs (18)
Leadership (6)
Legal (689)
Liver cancer (2)
Longevity (2)
Lung cancer (23)
Lymphoma (9)
Management (5)
Manufacturing (14)
MASH (2)
Medical device (464)
Medtech (465)
Mergers & acquisitions (405)
Metabolic disorders (42)
Multiple sclerosis (3)
Neurodegenerative disease (11)
Neuropsychiatric disorders (6)
Neuroscience (84)
NextGen: Class of 2026 (334)
Non-profit (217)
Obesity (23)
Opinion (38)
Ovarian cancer (3)
Pain (6)
Pancreatic cancer (21)
Parkinson's disease (5)
Patents (15)
Patient recruitment (16)
Peanut (3)
People (1044)
Pharmaceutical (1)
Pharmacy benefit managers (10)
Phase 1 (440)
Phase 2 (734)
Phase 3 (577)
Pipeline (148)
Policy (49)
Postmarket research (70)
Preclinical (188)
Prostate cancer (7)
Psychedelics (2)
Radiopharmaceuticals (3)
Rare diseases (42)
Real estate (64)
Recruiting (6)
Regulatory (831)
Reports (2)
Research institute (73)
Resumes & cover letters (66)
RNA editing (1)
RSV (3)
Schizophrenia (7)
Series A (2)
Series B (2)
Sickle cell disease (1)
Special edition (2)
Spinal muscular atrophy (3)
Sponsored (1)
Startups (64)
Supply chain (1)
Tariffs (6)
The Weekly (6)
Vaccines (54)
Venture capital (4)
Weight loss (12)
Women's health (1)
Worklife (6)
Date
Last 7 days (9)
Last 30 days (44)
Last 365 days (851)
2026 (66)
2025 (860)
2024 (884)
2023 (914)
2022 (1410)
2021 (1413)
2020 (1613)
2019 (1511)
2018 (1122)
2017 (855)
2016 (730)
2015 (906)
2014 (681)
2013 (502)
2012 (678)
2011 (743)
2010 (613)
Location
Africa (66)
Alabama (1)
Alaska (1)
Arizona (4)
Asia (701)
Australia (183)
California (222)
Canada (50)
China (13)
Colorado (2)
Connecticut (12)
Delaware (9)
Europe (2604)
Florida (30)
Georgia (3)
Illinois (28)
India (1)
Indiana (6)
Japan (15)
Kansas (3)
Louisiana (1)
Maine (2)
Maryland (21)
Massachusetts (180)
Michigan (6)
Minnesota (26)
Nebraska (1)
Nevada (2)
New Hampshire (1)
New Jersey (58)
New York (80)
North Carolina (26)
Northern California (67)
Ohio (5)
Oregon (1)
Pennsylvania (57)
Rhode Island (1)
South America (85)
Southern California (131)
Texas (90)
United States (850)
Utah (22)
Virginia (3)
Washington D.C. (6)
Washington State (15)
18,260 Results for "gn hearing".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
GENFIT: GNS561 Shows Promising Antitumor Activity in Combination Therapy
December 11, 2025
·
10 min read
Gene editing
Lilly Leans Into Hearing Loss in $1.12B+ Gene Editing Pact With Seamless
The deal will help bolster Eli Lilly’s growing hearing loss portfolio, which is anchored by the gene therapy AK-OTOF.
January 28, 2026
·
2 min read
·
Tristan Manalac
Press Releases
SINOVAC Announces Nasdaq Hearings Panel Grants Continued Listing
January 22, 2026
·
3 min read
Press Releases
Envoy Medical Secures Four New Global Patents, Expanding Its Leadership Position in Fully Implantable Hearing Technology
Patents strengthen Envoy Medical’s innovation pipeline and protect next-generation cochlear implant solutions for individuals living with hearing loss.
September 10, 2025
·
8 min read
Press Releases
US Patent Issued for the First Nutraceutical Supplement Clinically Proven to Preserve or Improve Hearing, with Additional Claims to Reduce Dementia Risk
ACEMg® is designed to preserve hearing in people who have experienced hearing loss
June 27, 2025
·
1 min read
Press Releases
Annual General Meeting 2025 – GN Store Nord A/S
March 13, 2025
·
3 min read
Press Releases
Envoy Medical Secures Three New Patents, Strengthening Leadership in Fully Implantable Hearing Technology
Patents issued in the U.S., Australia, and Hong Kong advance Envoy Medical’s innovation pipeline and protect next-generation cochlear implant solutions for individuals living with hearing loss.
August 20, 2025
·
8 min read
GN expands groundbreaking ReSound OMNIA family enabling more people to hear their best in noise
GN Hearing, the global leader in hearing aid innovation, announces the expansion of the popular ReSound OMNIA family, providing more options to address the biggest unmet need for people with hearing loss: hearing speech in noisy environments.
February 7, 2023
·
4 min read
Press Releases
Seamless Therapeutics Announces Global Research Collaboration with Lilly to Develop Programmable Recombinase-based Therapeutics for Hearing Loss
January 28, 2026
·
3 min read
Press Releases
Hearing Device Coverage Clarification Act Reintroduced in House and Senate
Seek to clarify that certain hearing implants are prosthetics and therefore not subject to the hearing aid coverage exclusion, allowing for potential Medicare coverage
March 17, 2025
·
7 min read
1 of 1,826
Next
